| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/09/2007 | EP1782802A1 Combined use of pterostilbene and quercetin for the production of cancer treatment medicaments |
| 05/09/2007 | EP1782800A2 JAK/STAT pathway inhibitors and the uses thereof |
| 05/09/2007 | EP1781777A1 Method for the genetic activation of cells and uses of said cells |
| 05/09/2007 | EP1781689A1 Conjugates and therapeutic uses thereof |
| 05/09/2007 | EP1781674A1 Enantiomers of selected fused pyrimidones and uses in the treatment and prevention of cancer |
| 05/09/2007 | EP1781673A1 Selected fused heterocyclics and uses thereof |
| 05/09/2007 | EP1781667A1 Benzothienopyridines for use as inhibitors of eg5 kinesin |
| 05/09/2007 | EP1781664A1 Inhibitors of vegf receptor and hgf receptor signaling |
| 05/09/2007 | EP1781660A1 Imidazopyrazine as tyrosine kinase inhibitors |
| 05/09/2007 | EP1781654A1 Pyrrolo-pyridine kinase modulators |
| 05/09/2007 | EP1781653A1 3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors |
| 05/09/2007 | EP1781645A1 Oxazolo-naphthyl acids as plasminogen activator inhibitor type-1(pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
| 05/09/2007 | EP1781640A1 2,4-di(aminophenyl)pyrimidine derivatives as plk inhibitors |
| 05/09/2007 | EP1781639A1 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 05/09/2007 | EP1781622A2 Integrin alpha-v beta-3 antagonists for use in imaging and therapy |
| 05/09/2007 | EP1781618A1 Sigma receptor inhibitors |
| 05/09/2007 | EP1781604A1 Bis(thio-hydrazide amide) salts for treatment of cancers |
| 05/09/2007 | EP1781377A2 Elastase inhibitor in leukemia |
| 05/09/2007 | EP1781375A2 Mixture of catechins or polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (bph) |
| 05/09/2007 | EP1781325A2 Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses |
| 05/09/2007 | EP1781321A1 A method of treating cancer comprising a vegf-b antagonist |
| 05/09/2007 | EP1781300A1 Muscarinic antagonists with parp and sir modulatng activity as agents for inflammatory diseases |
| 05/09/2007 | EP1781284A1 Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma |
| 05/09/2007 | EP1781280A2 Androgen modulators |
| 05/09/2007 | EP1781271A1 Arylidenes for the treatment of estrogen related receptor-alpha mediated diseases |
| 05/09/2007 | EP1781255A1 Compositions and methods for treating leukemia |
| 05/09/2007 | EP1781096A1 Cancer selective auxotrophs |
| 05/09/2007 | EP1589967B1 Benzthiazole-3 oxides useful for the treatment of proliferative disorders |
| 05/09/2007 | EP1573031A4 Androgen regulated nucleic acid molecules and encoded proteins |
| 05/09/2007 | EP1572675B1 New alpha-glucosidase inhibitors and their synthesis from a natural source |
| 05/09/2007 | EP1501796B1 3-(pyridinyl-amino)-1h-indole-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 05/09/2007 | EP1487434B1 Botanical extract compositions with anti-cancer activity comprising isoliquiritigenin |
| 05/09/2007 | EP1450799B9 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 05/09/2007 | EP1408970B1 Indolines and tetrahydro-quinolines as prodrugs for tumour treatment |
| 05/09/2007 | EP1364959B1 Crystal of pyrimidine nucleoside derivative |
| 05/09/2007 | EP1313882B1 Diagnosis and treatment of prostate cancer |
| 05/09/2007 | EP1272477B1 Pyrimidine compounds |
| 05/09/2007 | EP1254169B1 Methods relating to modulation of th2 cell subset activity by modulation of xbp-1 activity |
| 05/09/2007 | EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 05/09/2007 | EP1169058B1 Insulin-like growth factor binding protein-4 protease |
| 05/09/2007 | EP1137792B1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 05/09/2007 | EP0969720B1 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 05/09/2007 | EP0708660B1 Compounds useful for preparing prodrugs of protein tyrosine kinase inhibitors |
| 05/09/2007 | EP0692029B1 Genetically engineered glutaminase and its use in therapy |
| 05/09/2007 | CN1960766A Novel G-CSF conjugates |
| 05/09/2007 | CN1960756A Cytotoxicity mediation of cells evidencing cell membrane surface expression of CD63 |
| 05/09/2007 | CN1960755A Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 05/09/2007 | CN1960754A Cancer regulation antibody |
| 05/09/2007 | CN1960751A Vaccine compositions obtained from streptomyces |
| 05/09/2007 | CN1960750A Therapeutic use of anti-CS1 antibodies |
| 05/09/2007 | CN1960737A Treatment with oxaliplatin and EGFR-inhibitor |
| 05/09/2007 | CN1960734A Treatment of t-cell lymphoma using 10-propargyl-10-deazaaminopterin |
| 05/09/2007 | CN1960733A Combination product comprising SRC kinase inhibitor AZD0530 and an antioestrogen or EGFR-TK-inhibitor |
| 05/09/2007 | CN1960732A Treatment with gemcitabine and EGFR-inhibitor |
| 05/09/2007 | CN1960730A Treatment with irinotecan and EGFR-inhibitor |
| 05/09/2007 | CN1960729A 伊立替康制剂 Irinotecan preparations |
| 05/09/2007 | CN1960728A Conformationally constrained SMAC mimetics and the uses thereof |
| 05/09/2007 | CN1960725A Tetra-cyclic carboline derivatives useful in the inhibition of angiogenesis |
| 05/09/2007 | CN1958805A Method for biologic preparing 4, 4 dihydric bowel lactone from burdock glycoside |
| 05/09/2007 | CN1958794A Method for preparing mutant code cDNA of apoptosis induction ligand related to human tumor necrosis factor, and application |
| 05/09/2007 | CN1958613A Mucinl antibody and usage |
| 05/09/2007 | CN1958612A MUC5AC antibody and usage |
| 05/09/2007 | CN1958611A Mucin antibody in sera, and usage |
| 05/09/2007 | CN1958610A Medication of guiding antibody for anti leukaemia in monocarpotic cellularity |
| 05/09/2007 | CN1958606A Recombined composite epitope antigen of liver cancer, preparation method, and application of preparing medication for specific immunity treatment of liver cancer |
| 05/09/2007 | CN1958601A Quick separating and purifying protein 1 of singkwa fowelgourd |
| 05/09/2007 | CN1958597A Triterpene saponin compound of cycro jackfruit alkyl, and effect for anti tumor |
| 05/09/2007 | CN1958590A Derivative of oxazole p-camptothecin ester, preparation method and application |
| 05/09/2007 | CN1958572A Compound in category of dihydro quinolines, preparation method, and composition of medication |
| 05/09/2007 | CN1958075A Compsn of anti-blood generating factor contg adeno-associated virus mediation and its application |
| 05/09/2007 | CN1958017A Medication for treating leukaemia |
| 05/09/2007 | CN1958012A Extractive of volatile oil of datura flower, and application |
| 05/09/2007 | CN1958011A Application of extractive and effective parts of datura flower in preparing medication for anti tumor |
| 05/09/2007 | CN1957995A Liquid for dispelling tumor |
| 05/09/2007 | CN1957956A Composition of multiple fungus possessing effects of anti tumour and adjusting immunity preparation method, and usage |
| 05/09/2007 | CN1957954A Water immersion object from Qinba selenium mushroom, preparation method and application |
| 05/09/2007 | CN1957944A Application of yew amylose in pharmacy |
| 05/09/2007 | CN1957930A Application of honokiol in preparing sensitization agent for tumour chemotherapy |
| 05/09/2007 | CN1957927A Fat micro sphere preparation of triterpenoid saponin and derivative, and fabricating method |
| 05/09/2007 | CN1957926A Controlled release microparticles of Nano medication of curcumin, and preparation method |
| 05/09/2007 | CN1957923A A kind of controlled release injection of carried fluorouracil and synergis |
| 05/09/2007 | CN1957922A Controlled release agent of containing fluorouracil and synergis |
| 05/09/2007 | CN1957921A Controlled release injection of carried fluorouracil and synergis |
| 05/09/2007 | CN1957920A Anti cancer controlled release agent of carried fluorouracil and synergist |
| 05/09/2007 | CN1957919A Controlled release agent of containing fluorouracil and synergist |
| 05/09/2007 | CN1957916A Anti cancer controlled release agent of carried interstitial hydrolytic agent and derivative of Epothilone |
| 05/09/2007 | CN1957915A Anti cancer controlled release agent of carried interstitial hydrolytic agent and medication of cell toxin |
| 05/09/2007 | CN1957914A Anti cancer controlled release agent of carried interstitial hydrolytic agent and medication of cell elements |
| 05/09/2007 | CN1957913A Composition of anti cancer medication prepared from carried platinum category compound and consubstantial hydrolytic agent |
| 05/09/2007 | CN1957912A Anti cancer controlled release formulation of containing interstitial hydrolytic agent |
| 05/09/2007 | CN1957911A Controlled release formulation for anti entity tumour |
| 05/09/2007 | CN1957910A Anti cancer controlled release formulation of containing consubstantial hydrolytic agent |
| 05/09/2007 | CN1314963C Substance containing shiitake mushroom hypha extract for soreening LAK activity and method for screening LAK activity by using the same |
| 05/09/2007 | CN1314811C Recombinant chimeric eucaryotic expression vector Cb1-Grb7(SH2)-RING and use of anti-tumour gene drug |
| 05/09/2007 | CN1314808C Pyocyanine gene and target gene therapy of cancer with its packing and guiding protein composite |
| 05/09/2007 | CN1314807C Gene clone and expression of RGD die body protein of oral gland in Japan lamprey possessing function for anti tumour |
| 05/09/2007 | CN1314806C Miniaturized polypeptide of anti EB Virus tumour, application and preparation method |
| 05/09/2007 | CN1314805C A novel APO and antibody thereof and preparation and use |
| 05/09/2007 | CN1314803C Cell proliferation inhibitors containing anti-glypican 3 antibody |
| 05/09/2007 | CN1314712C Preparation for fungus extracellular polysaccharide compound and application thereof |